Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update

Area of Science:

• Biochemistry
• Pharmacology
• Natural Products Chemistry

Background:

• Protein tyrosine phosphatase 1B (PTP1B) is a key therapeutic target for type 2 diabetes and obesity.
• PTP1B negatively regulates insulin and leptin signaling, making its inhibition crucial for metabolic health.
• Existing synthetic PTP1B inhibitors have faced clinical discontinuation due to adverse effects or poor selectivity.

Purpose of the Study:

• To review recent advancements in PTP1B inhibitors derived from natural products.
• To highlight the potential of natural compounds as effective and safe therapeutic agents.
• To provide insights for the development of novel PTP1B inhibitors.

Main Methods:

• Literature review of scientific publications on PTP1B inhibitors from natural sources.
• Analysis of chemical diversity and inhibitory activity of natural product-derived PTP1B inhibitors.
• Summary of research progress and challenges in the field.

Main Results:

• Natural products exhibit broad chemical diversity and potent PTP1B inhibitory activity.
• Many natural PTP1B inhibitors demonstrate favorable safety profiles compared to synthetic counterparts.
• Recent studies showcase significant progress in identifying and characterizing novel natural inhibitors.

Conclusions:

• Natural products represent a valuable resource for developing next-generation PTP1B inhibitors.
• Further research into natural compounds can lead to effective treatments for metabolic diseases.
• Targeting PTP1B with natural product-derived molecules offers a promising therapeutic strategy.